Subscribe To
Lifshitz law pllc announces investigations of rain oncology, inc. (nasdaq: rain), danaher corp. (nyse: dhr), bausch health companies, inc. (nyse: bhc), and at&t inc. (nyse: t)
NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — Rain Oncology, Inc. (NASDAQ: RAIN) Lifshitz Law PLLC announces investigation into possible securities la...
September 2, 2023, 11:00 pm
Rosen, global investor counsel, encourages bausch health companies inc. investors with losses to secure counsel before important deadline in securities class action – bhc
NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ba...
September 2, 2023, 1:15 am
Globus medical completes merger with nuvasive
—Creates leading global musculoskeletal company——Robust portfolio well-positioned for long-term g...
September 1, 2023, 12:33 pm
Why vinfast auto stock crashed this week -- and could keep falling
VinFast stock has been cut in half this week. VinFast's ownership is complex, but the publicly traded shares represent only a min...
September 1, 2023, 10:20 am
Pepgen announces presentations at the 2023 myotonic dystrophy foundation annual conference, ottawa neuromuscular disease meeting, and h.c. wainwright 25th annual global investment conference
BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu...
September 1, 2023, 8:00 am
Igo limited (ipgdf) q4 2023 earnings call transcript
IGO Limited (OTCPK:IPGDF) Q4 2023 Earnings Conference Call August 30, 2023 8:00 PM ET Company Participants Matt D...
August 31, 2023, 2:25 am
Nzd/usd spike above 60 usc short-lived
Softer than expected US economic data increased expectations of the Fed remaining on hold in September which underpinned equities and contributed to l...
August 30, 2023, 8:44 pm
Why ambarella's 20% decline is a strong signal for new investment
Ambarella's NASDAQ: AMBA stock shed 20% following the Q2 report and guidance, but don't read too much bearishness into the news. The company is focuse...
August 30, 2023, 12:59 pm
Fibrogen (fgen) fails to meet goals in dmd study, stock down 23%
FibroGen (FGEN) falls 22.7% as its late-stage study of pamrevlumab for the treatment of ambulatory patients with Duchenne m...
August 30, 2023, 12:46 pm
Fibrogen stock plummets as muscular dystrophy drug trial fails
FibroGen Inc (NASDAQ:FGEN) plummeted some 27% lower in Wednesday's early deals after revealing that its intended treatment for Duchenne m...
August 30, 2023, 9:39 am
Fibrogen shares fall after failure in late-stage study of duchenne muscular dystrophy treatment
Shares of FibroGen Inc. FGEN, +3.23% fell 23% premarket on Wednesday after the company said its investigational treatment for Duchenne m...
August 30, 2023, 7:55 am
Fibrogen announces topline results from lelantos-2, a phase 3 clinical study of pamrevlumab in ambulatory duchenne muscular dystrophy
– Study did not meet the primary endpoint – – Pamrevlumab was generally safe and well tolerated – SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE...
August 29, 2023, 8:15 pm
Si-bone to present at morgan stanley 21st annual global healthcare conference on september 12, 2023
SANTA CLARA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving m...
August 29, 2023, 4:09 pm
Eur/jpy price analysis: despite rising, intra-day technicals favor bears
As the Asian session begins, the EUR/JPY registers minuscule losses after posting 0.31% of gains on Mon...
August 28, 2023, 10:59 pm
Nuscale power: mixed feelings about this stock
Nuscale Power Corporation's SMR technology offers a flexible and adaptable solution for nuclear power g...
August 28, 2023, 2:51 pm
Bud light falls further, modelo extends lead as best-selling us beer
After toppling Bud Light to become the best-selling beer brand in the U.S. on the year, Modelo Especial has extended its lead over the beleaguered Anh...
August 28, 2023, 2:45 pm
Scholar rock: the market isn't enthusiastic despite decent clinical data
Scholar Rock Holding Corp. is developing a growth factor targeted therapy called apitegromab for Spinal Musc...
August 27, 2023, 9:13 am
Anheuser-busch inbev: do signs of a recovery make the stock a buy?
The boycott on Bud Light in the United States shows signs of softening. Anheuser-Busch's total business...
August 27, 2023, 9:09 am
Rosen, a trusted and leading law firm, encourages bausch health companies inc. investors to secure counsel before important deadline in securities class action – bhc
NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ba...
August 26, 2023, 3:00 pm
Here's how bud light stock reacted to losing no.1 beer spot in 2023
Earlier this year, Anheuser Busch (NYSE: BUD), the company behind Bud Light, experienced a sharp declin...
August 25, 2023, 7:54 am